Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Guardant Health Inc. Common Stock (GH) vs ProShares Ultra QQQ ETF (QLD) Price & Performance

Guardant Health Inc. Common StockTrade
ProShares Ultra QQQ ETFTrade

Price performance (Past 24H)

Key statistics

Guardant Health Inc. Common Stock vs ProShares Ultra QQQ ETF — how do they compare? Guardant Health Inc. Common Stock trades at $168.44 (market cap $22.22B), while ProShares Ultra QQQ ETF trades at $97.71 (market cap $15.38B). The key difference: Guardant Health Inc. Common Stock is the larger of the two by market cap, and ProShares Ultra QQQ ETF is more actively traded (4,844,085 versus 1,589,453). Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and ProShares Ultra QQQ ETF for 37 Days on average.

GHQLD
Market Cap
$22.22B$15.38B
Volume
1,589,4534,844,085
Sector
HealthLeveraged / Inverse
52-Week High
$187.22$100.77
52-Week Low
$61.73$57.16
Typical Hold Time
0 Days37 Days
Enterprise Value
$22.86B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Guardant Health Inc. Common Stock

No Aura AI signal available yet.

ProShares Ultra QQQ ETF

QLD trades at $100.23, down 0.54% on the day, with technical indicators showing a bullish moving average signal but overbought RSI conditions. The ETF maintains support at $99 and resistance at $101, with institutional buying activity noted in recent filings. Recent news highlights QLD's resilience compared to more leveraged alternatives during market downturns.

The outlook remains cautiously optimistic given strong technical momentum, though overbought conditions suggest potential near-term consolidation. Key risks include Federal Reserve policy impacts and Nasdaq volatility, while institutional accumulation supports medium-term bullish sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GH
100% Buy0% Sell
Avg holding period · 0 Days
QLD
51% Buy49% Sell
Avg holding period · 37 Days

About Guardant Health Inc. Common Stock

Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.

Read more on GH →

About ProShares Ultra QQQ ETF

QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on QLD →